1
|
Mavilakandy A, Antoun I, Kotb A, Koev IM, Barker J, Vali Z, Sidhu B, Pooranachandran V, Li X, Ng GA. Outcomes of very high-power short-duration ablation using 90w for pulmonary vein isolation in patients with atrial fibrillation: a real world observation study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Pulmonary vein isolation (PVI) ablation is the established gold standard therapy for patients with symptomatic drug refractory atrial fibrillation (AF). Advancements in radiofrequency (RF) ablation, have led to the development of the novel contact force-sensing temperature-controlled very high-power short-duration (vHPSD) RF ablation. This setting delivers 90W for up to 4 seconds with a constant irrigation flow rate of 8ml/min. The aim of this study was to compare procedural outcomes and safety with conventional radiofrequency ablation.
Methods
An observational study was conducted with patients who underwent first time PVI ablation from 2019 to 2021. The cohort was divided in to: 1) vHPSD ablation – QMODE+ via QDOT MICRO catheter, 2) QMODE via QDOT MICRO catheter and 3) Conventional power-controlled RF (PCRF) ablation via THERMOCOOOL SMARRTOUCH SF (STSF) catheter. The QMODE+ vHPSD ablation group was prospectively recruited while the QMODE and PCRF group were retrospectively collected. Primary outcomes were procedural success, PVI duration, ablation duration and incidence of perioperative adverse events. Secondary outcomes were intraprocedural morphine and midazolam requirement.
Results
A total of 155 patients were included in the study with 80, 30 and 45 patients in the QMODE+ (vHPSD), QMODE and PCRF, respectively. PVI was successfully attained in all patients. QMODE+ (vHPSD) demonstrated significantly reduced time required for PVI and total energy application in comparison to the QMODE and PCRF groups (68.3±3.30 vs. 92.9±4.86 vs. 93.6±4.34 min, P<0.0001; 9.7±0.452 vs. 33.9±0.452 vs. 36.0±1.56 min, P<0.0001, respectively) (Figure 1). Intravenous morphine and midazolam requirement was lower in the QMODE+ (vHPSD) group compared to the QMODE and PCRF groups (10.3±0.45 vs. 16.1±0.935 vs. 15.3±0.686 mg, P<0.0001; 4.05±0.402 vs. 8.63±1.07 vs. 8.58±0.821 mg, P<0.0001) (Figure 2). QMODE+ (vHPSD) observed a non-significant reduction in fluoroscopy time compared to QMODE and PCRF. One cardiac tamponade were observed in both the QMODE+ (vHPSD) and QMODE group while the PCRF group exhibited an embolic stoke and two pericardial effusions that did not require drainage.
Conclusion
In this study, QMODE+ (vHPSD) demonstrated a comparable safety profile to the other treatment arms. Procedural duration and energy application time was substantially reduced while a non-significant reduction was observed for fluoroscopy time for QMODE+. Furthermore, sedation requirement was reduced and thus potentially conveyed greater patient tolerability of the procedure when conducted with QMODE+.
Notwithstanding the limitations of observational study design, these preliminary findings are promising with respect to periprocedural outcomes and safety of QMODE+. Longer term outcomes with respect to maintenance of sinus rhythm and symptomatic burden will be essential to assessing the overall efficacy of this novel technology.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Mavilakandy
- University of Leicester , Leicester , United Kingdom
| | - I Antoun
- University of Leicester , Leicester , United Kingdom
| | - A Kotb
- University of Leicester , Leicester , United Kingdom
| | - I M Koev
- University of Leicester , Leicester , United Kingdom
| | - J Barker
- University of Leicester , Leicester , United Kingdom
| | - Z Vali
- University of Leicester , Leicester , United Kingdom
| | - B Sidhu
- University of Leicester , Leicester , United Kingdom
| | | | - X Li
- University of Leicester , Leicester , United Kingdom
| | - G A Ng
- University of Leicester , Leicester , United Kingdom
| |
Collapse
|
2
|
Vali Z, Mistry A, Velu S, Sidhu B, Li X, Pooranachandran V, Lazdam M, Ibrahim M, Sandilands A, Somani R, Stafford P, Ng GA. 128Non-invasive 3D mapping of earliest activation of premature ventricular complexes originating from intracardiac structures to guide catheter ablation. Europace 2020. [DOI: 10.1093/europace/euaa162.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Research funding from Catheter Precision, Inc.
Introduction
Catheter ablation for ventricular arrhythmias such as premature ventricular complexes and ventricular tachycardia is an established management approach. Non-invasive mapping to localise the earliest activation (site of origin) on the myocardium may help guide ablation. Established ECGi methods using the inverse solution to reconstruct epicardial electrograms are unable to accurately locate arrhythmias from the endocardium or from intracardiac structures. VIVO™ (Catheter Precision) is a novel vectorcardiography based 3D mapping system that may be able to localise arrhythmias from any part of the ventricle.
Methods
We reviewed our initial experience utilising this mapping system to guide catheter ablation of ventricular ectopics from the inter-ventricular septum, coronary cusp or papillary muscle. A patient-specific 3D heart and torso model was created using semi-automated segmentation of MRI or CT scan images. A 3D topographic image of the patient’s torso was taken to accurately position surface ECG electrode locations onto the 3D heart-torso model. An ECG of the PVC was imported from LabSystemPro (Bard) into VIVO™ for analysis prior to ablation. The result was then compared with the site of earliest activation identified using invasive electro-anatomical (EA) mapping.
Results
VIVO™ was used in 12 cases where the PVC was localised to an intracardiac structure – six papillary muscle, four to the septum and two from the coronary cusp. VIVO™ was able to accurately localise the earliest activation site when compared to the invasive map in 5/6 papillary muscle cases, 3/4 septal cases and 2/2 coronary cusp cases. Ablation was acutely successful in all cases. One additional patient had a PVC localised non-invasively to the postero-medial papillary muscle, however an invasive 3D electro-anatomical map or ablation was not performed.
In three cases we were able to merge the 3D geometry of the non-invasive map from VIVO™ into the Carto™ system to guide mapping and ablation in real time (see figure).
Conclusion
Our experience shows promising results for accurate non-invasive localisation of ventricular arrhythmias originating from intracardiac structures. Non-invasive localisation is of particular value in cases where the arrhythmia is infrequent, difficult to induce or poorly tolerated haemodynamically. The two cases where PVC localisation was inaccurate were performed using an older version of the software. With recent refinements, localisation is anticipated to be improved further.
We also present the first experience of combining the VIVO™ geometry with the real-time invasive EA map. This has potential to significantly speed up mapping time and reduce the need for expensive multi-polar catheters by allowing the operator to see their target in real time 3D. Further work is ongoing to validate the accuracy of VIVO™ prospectively and quantitatively.
Abstract Figure. VIVO map merged with Carto LV geometry
Collapse
Affiliation(s)
- Z Vali
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - A Mistry
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - S Velu
- University Hospitals of Leicester NHS Trust, Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - B Sidhu
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - X Li
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - V Pooranachandran
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - M Lazdam
- University Hospitals of Leicester NHS Trust, Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - M Ibrahim
- University Hospitals of Leicester NHS Trust, Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - A Sandilands
- University Hospitals of Leicester NHS Trust, Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - R Somani
- University Hospitals of Leicester NHS Trust, Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - P Stafford
- University Hospitals of Leicester NHS Trust, Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - G A Ng
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
3
|
Li X, Sidhu B, Almeida TP, Ehnesh M, Mistry A, Vali Z, Pooranachandran V, Chu GS, Stafford PJ, Schlindwein FS, Ng GA. P439Could regional electrogram desynchronization identified using mean phase coherence be potential ablation targets in persistent atrial fibrillation? Europace 2020. [DOI: 10.1093/europace/euaa162.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
This work was supported by the NIHR Leicester Biomedical Research Centre. XL was funded by MRC(MR/S037306/1) and BHF (PG/18/33/33780)
Background
It remains controversial as to whether rotors detected using phase mapping during persistent atrial fibrillation (persAF) represent main drivers of the underlying mechanism as others found rotors to be located near line of conduction block. Regional electrogram desynchronization (RED) has been suggested as successful targets for persAF ablation, but automatic tools and quantitative measures are lacking.
Purpose
We aim to use mean phase coherence (MPC) to automatically identify RED regions during persAF. This method was compared with phase singularity density (PSD) maps.
Methods
Patients undergoing left atrial (LA) persAF ablation were enrolled (n = 10). 2048-channel virtual electrograms (VEGMs) were collected from each patient using non-contact mapping (St Jude Velocity System, Ensite Array) for 10 seconds. To remove far field ventricular activities, QRS onset and T wave end locations were detected from ECG lead I (Figure 1A) and only the VEGM segments from T end to QRS onset were included in the analysis. VEGMs were reconstructed using sinusoidal wavelets fitting and the phase of VEGMs determined using Hilbert transform. Phase singularities (PS) were detected using the topological charge method and repetitive PSD maps were generated. RED was defined as the average of MPC of each node against direct neighbouring nodes on the 3D mesh (Figure 1A-B). Linear regression analysis was used to compare the average MPC vs. PSD and vs. the standard deviation of MPC (MPC_SD).
Results
A total of 221,184 VEGM segments were analysed with mean duration of 364.2 milliseconds. MPC has shown the ability to quantify the level of synchronisation between VEGMs (Figure 1B). Inverse correlation was found between PSD and average MPC values for all 10 patients (p < 0.0001, Figure 1C). Average MPC and MPC_SD were found to be inversely correlated (p < 0.0001, Figure 1C). Spatially, similar graphic patterns can be found from LA MPC maps and PSD maps for all patients (Figure 1D).
Conclusion
We have proposed a method to quantify the level of synchronisation between VEGMs. Phase density mapping showed a considerable agreement with RED regions reflecting regional conducting delays, which supports the previous finding where rotors found at conduction block. Inverse correlation between local average MPC and MPC_SD suggests that conduction delays of the identified regions are not heterogenous, posing directional preferences. Rather than solely looking for rotational activities, this method could identify comprehensive RED regions, which may also explain the conflicting results from different studies targeting rotational activities, where incomplete subsets of RED regions could have been targeted. Atrial RED regions can easily be identified with simultaneously collected electrograms from multi-polar catheters and should be targeted in future persAF studies.
Abstract Figure 1
Collapse
Affiliation(s)
- X Li
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - B Sidhu
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - T P Almeida
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - M Ehnesh
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - A Mistry
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - Z Vali
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - V Pooranachandran
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - G S Chu
- University of Melbourne, Melbourne, Australia
| | - P J Stafford
- Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - F S Schlindwein
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - G A Ng
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
4
|
Pooranachandran V, Mistry A, Vali Z, Li X, Sidhu B, Ng GA. P1113Patchy localisation of late gadolinium enhancement associated with ventricular arrhythmia in dilated cardiomyopathy. Europace 2020. [DOI: 10.1093/europace/euaa162.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
None
Introduction
Myocardial fibrosis detected using late gadolinium enhancement(LGE) on cardiac magnetic resonance(CMR) imaging holds prognostic value in dilated cardiomyopathy(DCM). Recent reports have demonstrated the localisation of LGE to be promising predictors of ventricular arrhythmic (VA).Aim: To determine the localisation of LGE associated with high risk of VA in DCM patients. Methods: Retrospective review of consecutive DCM patients(n = 85) implanted with an implantable cardioverter defibrillator(ICD) at a single tertiary centre between 2011-2018. All patients with insufficient follow-up data, cardiac channelopathies, primary valvular pathology and congenital heart disease were excluded from analysis(n = 11). Details of VA occurrence were obtained from medical and pacing notes. VA was defined as VA causing haemodynamic compromise or appropriate device therapy (anti-tachycardia pacing/shock). Localisation of LGE was defined as midwall, patchy, subepicardial or transmural. Left ventricular ejection fraction(LVEF) <35% was defined as severely impaired function. Results:74 DCM patients implanted with an ICD were identified for analysis; LGE was observed in 18(60%) VA and 29(66%) non-VA patients(p = 0.6). There was no observed difference in mean age for patients with and without LGE (68 ± 10 vs. 65 ± 10 years,p = 0.07). A significant difference was seen between localisation and VA (p = 0.04), with patchy LGE demonstrating a higher arrhythmic risk(p = 0.005). There was no association between LVEF and LGE(p = 0.2) however, a significant difference was seen in LVEF and arrhythmic risk, with a more severely impaired LV function seen in patients without VA(p = 0.01). Conclusion:This study has demonstrated a patchy LGE localisation to be strongly associated with ventricular arrhythmia in DCM. Whilst this is a valuable tool in risk stratification, a prospective study with a larger population is required to confirm the validity of this finding. Moreover, an additional method will need to be considered to identify high risk patients without LGE.
Ventricular Arrhythmia (n = 30) No Ventricular Arrhythmia (n = 44) P Value Male(%) 20(67%) 24(55%) p = 0.29 Age(Mean ± SD) 65 ± 12 65 ± 10 p = 0.36 LGE Midwall 10(56%) 24(83%) p = 0.04 Subepicardial 1(5.5%) 2(7%) p = 0.85 Transmural 1(5.5%) 2(7%) p = 0.85 Patchy 6(33%) 1(3%) p = 0.005 LVEF <35% 23(77%) 42(95%) p = 0.01
Collapse
Affiliation(s)
- V Pooranachandran
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - A Mistry
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - Z Vali
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - X Li
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - B Sidhu
- University of Leicester, Leicester, United Kingdom of Great Britain & Northern Ireland
| | - G A Ng
- Glenfield Hospital, Leicester, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|